These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5001133)

  • 1. Levodopa.
    Muenter MD
    Ann Intern Med; 1971 Nov; 75(5):795-7. PubMed ID: 5001133
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatment.
    Lee JE; Sweet RD; McDowell FH
    Ann Intern Med; 1971 Nov; 75(5):703-8. PubMed ID: 5122157
    [No Abstract]   [Full Text] [Related]  

  • 3. The drug treatment of parkinsonism.
    Stern GM
    J Med Assoc Thai; 1971 Dec; 54(12):939-46. PubMed ID: 5157147
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of severe Parkinson's disease by intraventricular injection of dopamine.
    Venna N; Sabin TD; Ordia JI; Mark VH
    Appl Neurophysiol; 1984; 47(1-2):62-4. PubMed ID: 6508279
    [No Abstract]   [Full Text] [Related]  

  • 5. L-dopa.
    Behav Neuropsychiatry; 1970; 2(5):173-5. PubMed ID: 5506991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychic disorders and somnolence].
    Houeto JL; Arnulf I
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S102-7. PubMed ID: 12690669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The history of dopamine and levodopa in the treatment of Parkinson's disease.
    Fahn S
    Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease.
    You H; Mariani LL; Mangone G; Le Febvre de Nailly D; Charbonnier-Beaupel F; Corvol JC
    Cell Tissue Res; 2018 Jul; 373(1):111-135. PubMed ID: 29516217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of dopamine on the vestibulo-ocular reflex in parkinsonism].
    Genco S; Puca FM; Serlenga L; Brignone A; Specchio LM
    Boll Soc Ital Biol Sper; 1975 Oct; 51(20):1375-81. PubMed ID: 1085152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reports on mental disorders in Parkinson disease in relation to treatment with L-dopa].
    Agostino R; Fabri S
    Riv Neurobiol; 1983; 29(4):577-84. PubMed ID: 6678478
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy.
    Botez MI; Barbeau A
    Int J Neurol; 1975; 10(1-4):222-32. PubMed ID: 1181311
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinsonism, levodopa, and intelligence.
    Loranger A; Sweet RD; Goodell H; McDowell F
    Int J Neurol; 1975; 10(1-4):276-81. PubMed ID: 1181314
    [No Abstract]   [Full Text] [Related]  

  • 13. [L-dopa therapy of parkinson syndrome].
    Kapfhammer HP; Kuss HJ; Rüther E
    Nervenarzt; 1985 Feb; 56(2):57-68. PubMed ID: 3920542
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current perspectives in the treatment of Parkinson disease].
    Rodríguez M; Palarea MD; Castro R; Pérez J; Arévalo R
    Med Clin (Barc); 1985 Nov; 85(15):633-40. PubMed ID: 2867259
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of l-dopa in parkinsonism.
    Paulson GW; Wiederholt WC; Allen JN; Shuttleworth EC; Friedman HM
    Ohio State Med J; 1969 Oct; 65(10):995-9. PubMed ID: 5347859
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical physiology of side effects in long-term L-DOPA therapy.
    Barbeau A
    Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mental disorders in patients with Parkinson's disease treated with L-dopa].
    Piccirilli M; Piccinin GL
    Clin Ter; 1981 Jun; 97(5):473-9. PubMed ID: 7273659
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic supersensitivity in parkinsonism.
    Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    Adv Neurol; 1975; 9():121-9. PubMed ID: 1146650
    [No Abstract]   [Full Text] [Related]  

  • 19. [Motor and mental complications in the long-term treatment of complicated Parkinson's disease with levodopa].
    Molina JA; Jiménez-Jiménez FJ; Ortí-Pareja M
    Rev Neurol; 1999 May 16-31; 28(10):982-90. PubMed ID: 10416237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Long term mental changes in levodopa-treated patients.
    Botez MI; Barbeau A
    Lancet; 1973 Nov; 302(7836):1028-9. PubMed ID: 4127251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.